Karim Lalji

Karim Lalji

Director/Miembro de la Junta en MEDICENNA THERAPEUTICS CORP. .

Fortuna: - $ al 31/05/2026

Health Technology
Consumer Services
Health Services

Perfil

Karim F.
Lalji
is Director at Medicenna Therapeutics Corp.
since 2024.
Mr. Lalji is Chief Business Officer at ME Therapeutics Holdings, Inc. since 2024.
Former roles include Chairman & Chief Executive Officer at Microbion Corp., Director-Business Strategy at Merck & Co., Inc., Director at MSI Methylation Sciences, Inc., Director-Overseers Board at Beth Israel Deaconess Medical Center, Inc., Director at The Centre for Drug Research & Development, Director at Accel-Rx, Vice President-New Products Planning at Sumitomo Pharma America, Inc., and Chief Commercial Officer at Correvio Pharma Corp.
from 2006 to 2015.
Education includes graduate studies at Harvard University and undergraduate studies at Simon Fraser University.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
25/09/2025 0 ( -.--% ) - $ 31/05/2026

Cargos activos de Karim Lalji

EmpresasCargoInicio
MEDICENNA THERAPEUTICS CORP. Director/Miembro de la Junta 15/08/2024
ME THERAPEUTICS HOLDINGS INC. Corporate Officer/Principal 25/10/2024

Antiguos cargos conocidos de Karim Lalji.

EmpresasCargoFin
CORREVIO PHARMA CORP. Corporate Officer/Principal 16/02/2015
Director/Miembro de la Junta -
Director Ejecutivo -
Director/Miembro de la Junta -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Karim Lalji.

Formación de Karim Lalji.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

17

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas12

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Services

Commercial Services

Finance

Health Technology

Health Technology